| Product Code: ETC071120 | Publication Date: Jun 2021 | Updated Date: Aug 2025 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Infectious Disease Biomarker Testing Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Infectious Disease Biomarker Testing Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Infectious Disease Biomarker Testing Market - Industry Life Cycle |
3.4 United States (US) Infectious Disease Biomarker Testing Market - Porter's Five Forces |
3.5 United States (US) Infectious Disease Biomarker Testing Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.6 United States (US) Infectious Disease Biomarker Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 United States (US) Infectious Disease Biomarker Testing Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 United States (US) Infectious Disease Biomarker Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in the US |
4.2.2 Growing awareness about early disease detection and prevention |
4.2.3 Technological advancements in biomarker testing leading to improved accuracy and efficiency |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for biomarker testing |
4.3.2 High costs associated with biomarker testing procedures |
4.3.3 Limited reimbursement policies for biomarker testing services |
5 United States (US) Infectious Disease Biomarker Testing Market Trends |
6 United States (US) Infectious Disease Biomarker Testing Market, By Types |
6.1 United States (US) Infectious Disease Biomarker Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Infectious Disease Biomarker Testing Market Revenues & Volume, By Product, 2018 - 2027F |
6.1.3 United States (US) Infectious Disease Biomarker Testing Market Revenues & Volume, By Assays, Kits and Reagents, 2018 - 2027F |
6.1.4 United States (US) Infectious Disease Biomarker Testing Market Revenues & Volume, By Instruments, 2018 - 2027F |
6.1.5 United States (US) Infectious Disease Biomarker Testing Market Revenues & Volume, By Services and Software, 2018 - 2027F |
6.2 United States (US) Infectious Disease Biomarker Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Infectious Disease Biomarker Testing Market Revenues & Volume, By Immunodiagnostics, 2018 - 2027F |
6.2.3 United States (US) Infectious Disease Biomarker Testing Market Revenues & Volume, By Clinical Microbiology, 2018 - 2027F |
6.2.4 United States (US) Infectious Disease Biomarker Testing Market Revenues & Volume, By PCR, 2018 - 2027F |
6.2.5 United States (US) Infectious Disease Biomarker Testing Market Revenues & Volume, By INAAT, 2018 - 2027F |
6.2.6 United States (US) Infectious Disease Biomarker Testing Market Revenues & Volume, By DNA Sequencing and NGS, 2018 - 2027F |
6.2.7 United States (US) Infectious Disease Biomarker Testing Market Revenues & Volume, By Other Technologies, 2018 - 2027F |
6.3 United States (US) Infectious Disease Biomarker Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Infectious Disease Biomarker Testing Market Revenues & Volume, By Physician Offices, 2018 - 2027F |
6.3.3 United States (US) Infectious Disease Biomarker Testing Market Revenues & Volume, By Reference Laboratories, 2018 - 2027F |
6.3.4 United States (US) Infectious Disease Biomarker Testing Market Revenues & Volume, By Hospitals, 2018 - 2027F |
6.3.5 United States (US) Infectious Disease Biomarker Testing Market Revenues & Volume, By Academic and Research Institutes, 2018 - 2027F |
6.3.6 United States (US) Infectious Disease Biomarker Testing Market Revenues & Volume, By Others, 2018 - 2027F |
7 United States (US) Infectious Disease Biomarker Testing Market Import-Export Trade Statistics |
7.1 United States (US) Infectious Disease Biomarker Testing Market Export to Major Countries |
7.2 United States (US) Infectious Disease Biomarker Testing Market Imports from Major Countries |
8 United States (US) Infectious Disease Biomarker Testing Market Key Performance Indicators |
8.1 Adoption rate of new biomarker testing technologies in the US healthcare system |
8.2 Number of research and development initiatives focusing on infectious disease biomarkers |
8.3 Percentage of healthcare providers offering biomarker testing services |
8.4 Rate of integration of biomarker testing in infectious disease treatment guidelines |
9 United States (US) Infectious Disease Biomarker Testing Market - Opportunity Assessment |
9.1 United States (US) Infectious Disease Biomarker Testing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United States (US) Infectious Disease Biomarker Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 United States (US) Infectious Disease Biomarker Testing Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 United States (US) Infectious Disease Biomarker Testing Market - Competitive Landscape |
10.1 United States (US) Infectious Disease Biomarker Testing Market Revenue Share, By Companies, 2021 |
10.2 United States (US) Infectious Disease Biomarker Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here